Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07855614) titled 'OPTIMized Diagnosis and Treatment System Based on AI and Multimodal Imaging Fusion for PCI (OPTIMAI-PCI)' on Sept. 28.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).

Primary Sponsor: Zhejiang Hospital

Condition: Coronary Artery Disease

Intervention: Device: AI-Based Imaging Fusion Guidance System

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: September 2026

Target Sample Size: 554

Countries of Recruitment: China

To know more, visit https://cli...